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A B S T R A C T
Most of the diagnostic laboratories in Libya often depend on western textbooks for CD4+- and CD8+ T-lymphocyte reference 
values. In this paper, we established reference ranges for the Libyan Toxoplasma, HIV, HBV, and HCV seronegative healthy 
pregnant women in all trimesters of pregnancy, and compared them with a control group of non-pregnant women. Whole-
blood samples were collected to provide normal ranges for CD4+ and CD8+ Lymphocyte subsets expressed as mean ± standard 
division. A total of 110 Libyan women who came from Tripoli and Zwara districts were investigated; 70 pregnant women 
(aged 27.8 ± 2.99, range 18-40 years old) and 40 non-pregnant women (aged 22.7±3.01, range 18-40 years old) were included as 
controls. All cases/controls were seronegative for toxoplasmosis, HIV, HBV and HCV. The CD4+ cell counts were 685±256 cell/!l 
at the first trimester (T1), 740±202 at T2, and 923±203 cell/!l at T3. While the CD8+ cell counts were 451±171 cell/!l at T1, 541±168 
at T2, and 753±190 cell/!l at T3. The CD4:CD8 ratios were 1.5±0.64 at T1, 1.4±0.51 at T2, and 1.2±0.36 at T3.  Moreover, the mean 
absolute CD4+ and CD8+ counts for the control group were 1001±232 cell/!l and 717±159 cell/!l respectively. 
Absolute counts of CD4+ and CD8+ cells in pregnant women were significantly lower as compared to controls (P<0.05). 
Statistically significant decrease in the CD4+ and CD8+ cell counts was reported during T1 (P<0.05). These values increased 
significantly during the T2, and was comparable to the controls during T3 (P>0.05). The absolute CD4+ and CD8+ cell counts 
decreased with age for both groups. Geographical variation was reported for the cell counts between Tripoli and Zwara 
district at T3. We established reference ranges of CD4+ and CD8+ T-lymphocytes for the Libyan healthy pregnant women and 
discussed their use as prognostic markers. Further cohorts with greater sample size may be required to define the stage of 
the disease in relation to the normal CD4+ and CD8+ T lymphocyte count subsets in the Libyan population.
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Introduction
   Toxoplasmosis, caused by a protozoan 
intracellular parasite Toxoplasma gondii, is 
one of the most common parasitic infections 
among humans and other warm-blooded 
animals (Montoya and Liesenfeld 2004). The 
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global seroprevalence of T. gondii in the general 
population varies widely and ranges between 
10 and 70% (Montoya and Liesenfeld 2004, Xiao, 
Yin et al. 2010, Sun, Lu et al. 2013). Most cases 
are asymptomatic and the clinical disease is 
generally not recognized. However, complications 
may occur in immunocompromised individuals 
including AIDS patients, transplant recipients, 
and patients undergoing cancer treatment 
(Liu, Wang et al. 2015). These complications can 
range from neuropsychiatric disorders to severe 
and potentially fatal encephalitis due to the 
reactivation of latent infections in AIDS patients 
(Halonen and Weiss 2013). 
T. gondii can pass through the placental 
barrier and infect the fetus (Jones, Lopez et al. 
2003, Montoya and Remington 2008). Primary 
infections of pregnant women are associated with 
potential congenital infections and spontaneous 
abortions. The severity of congenital infections 
and frequency of transmission are influenced 
by the stage of pregnancy in which maternal 
toxoplasmosis is acquired (Halonen and Weiss 
2013). 
Transmission is relatively low (< 20%) during 
the first trimester resulting in spontaneous abortion, 
hydrocephaly and mental retardation. However, it 
increases up to 80% by the end of the pregnancy 
(Jones, Lopez et al. 2003, Ortiz-Alegria, Caballero-
Ortega et al. 2010). The majority of the later cases 
are subclinical and resulting in asymptomatic 
infections or recurrent chorioretinitis that can 
lead to vision problems and potentially blindness 
(Montoya and Liesenfeld 2004).
The overall incidence of congenital toxoplasmosis 
in most populations, based upon serological 
methods, is from 1 in 1000 to 1 in 10,000 live births 
(Tenter, Heckeroth et al. 2000, Dubey and Jones 2008). 
However, a study measuring vertical transmission 
rates in humans using PCR detection of the umbilical 
cord found transmission rates of 19.8% (Hide, 
Gerwash et al. 2007). This suggests that human 
vertical transmission of Toxoplasma may be under 
reported when measured by serological methods 
(Hide, Morley et al. 2009).
Pregnancy is considered as physiological 
immunosuppression condition and can be 
associated with suppression of several 
immunological functions in order to accommodate 
the fetus (Dayama, Pandit et al. 2003). This includes 
the cell-mediated arm of the immune system 
which is conferred by the lymphocytes. These 
lymphocytes arise from hematopoietic stem cells 
in the bone marrow and have two major types: the 
B-cells, which when activated, di"erentiate into 
plasma cells and they secrete specific antibodies; 
and the T-cells, which rise in the thymus and have 
two main types: the first type di"erentiates on 
activation into cytotoxic T-cells, which directly kill 
cells infected with viruses, whereas the second 
type di"erentiates into cells that activate other 
cells such as B-cells and macrophages. The later 
includes the helper T- lymphocytes which assist 
the B-cells in antibody response and express the 
cluster determinant 4 (CD4+) molecules, while the 
cytotoxic T-cells express cluster determinant 8 
(CD8+) molecules (Janeway Jr, Travers et al. 2001). 
In several countries, prenatal screening 
of women is performed with the goals of early 
diagnosis and treatment of T. gondii infections 
(Roberts, Hedman et al. 2001). Moreover, serological 
diagnosis is routinely used to determine the 
immune status with regard to T. gondii infection 
(Jenum and Stray-Pedersen 1998). Estimation of 
CD4+ and CD8+ T-lymphocytes counts are used to 
measure the strength of an individual’s immune 
response and continues to be an important aspect 
for monitoring of immune function (Yang, Wu 
et al. 2015). They are also used as  indicators to 
begin prophylactic therapy against opportunistic 
infections (Force 1994). Other parameters that can 
be used to monitor the immune status include 
CD4+/CD8+ ratio, CD4+ and CD8+ percentages 
(Dayama, Pandit et al. 2003).
Available evidences suggest that the 
variations in CD4+ and CD8+T-lymphocytes could 
depend on certain important factors namely 
environment, ethnicity, genetic di"erences and 
dietary patterns in addition to age and gender 
(Tollerud, Clark et al. 1989, Lebranchu, Thibault et 
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al. 1991, Tsegaye, Messele et al. 1999, Fahey, Schnelle 
et al. 2000, Uppal, Verma et al. 2003). Moreover, CD4+ 
and CD8+T-lymphocytes counts are influenced by 
viral infections such as HIV, hepatitis B virus (HBV) 
and hepatitis C virus (HCV) (Zhou, Zhang et al. 2014), 
and parasitic infections such as toxoplasmosis which 
is highly prevalent in Libya. Seroprevalence among 
Libyan pregnant women ranges between 44.8% and 
50% (Kassem and Morsy 1991, Magrhi, Abudher et 
al. 2003, Mousa, Mohammad et al. 2011). Moreover, 
17.6% of women who su"ered from spontaneous 
apportion in Tripoli were Toxoplasma seropositive 
(Gashout, Lazrag et al. 2008), and the prevalence 
of congenital toxoplasmosis was found to be 44% 
(Alkhunfas 2008). The diagnosis of Toxoplasma is 
based on serology. Recent introduction of molecular 
detection of the parasite was reported in Tripoli 
(Gashout, Amro et al. 2016). The development 
of monoclonal antibodies and flow cytometry 
technology has made possible new approaches to 
leucocytes subset identification. However, no studies 
on T-lymphocyte subsets were conducted and no 
country-specific immunohaematological reference 
values are available in Libya. Most of the diagnostic 
laboratories often depend on western text books 
for CD4+- and CD8+ T-lymphocyte reference values, 
therefore interpretation of these values in pregnant 
women is inappropriately based on reference values 
established for healthy nonpregnant women. Hence, 
we conducted this study to established reference 
ranges for the Libyan healthy Toxoplasma and HIV, 
HBV, and HCV seronegative pregnant women in all 
trimesters of pregnancy and compared them with 
a non-pregnant group before using these levels as 
prognostic marker.
Methods 
Study settings and samples
Between 2008-2009, 70 pregnant women 
attended to antenatal Rahama clinic were 
selected for this study. Control group of 40 non-
pregnant women were included for comparison. 
Women with a history of any disease (e.g., 
complications in pregnancy, cough, cold or fever 
in the past one month) were excluded. 
Serologic tests
The ELISA test was used to assess 
Toxoplasmosis sero negativity for both groups. 
Approximately 5 ml of blood were collected 
from each subject. Serum was separated from 
the whole blood by centrifugation at 3000 rpm 
for 5 min and screened for anti-Toxoplasma 
IgG and IgM antibodies by using standard 
ELISA commercial kits (Human Gesellschaft für 
Biochemica und Diagnostica GmbH, Wiesbaden, 
Germany) in accordance with the manufacturer’s 
instruction. All samples were analyzed in the 
Libyan National Centre for Infectious Diseases 
Prevention and Control (LNCDC). Moreover, all 
serum samples were tested for HIV (anti-HIV 
Tetra ELISA, Biotest Co. Dreieich, Germany), HBV 
hepatitis B antibody (Anti-HBc EIA WELL, Radim, 
Italy), and HCV antibody (HCV-Ab ELISA, DRG Co., 
Marburg, Germany),
Flow cytometry Immunophenotyping
To provide normal ranges for CD4 and CD8 
Lymphocyte subsets, whole-blood samples (1 ml) 
were collected using sterile EDTA Vacutainer 
tubes. Three EDTA blood samples were collected 
from each pregnant woman and the test was 
performed every trimester of pregnancy. Samples 
were collected in triplicates between 9:00 -12:00 
AM to avoid any error in subset counts due to 
diurnal variations (Carmichael and Abayomi 
2006). Immunocytometry was done using CyFlow 
Counter machine (Partec, Münster, Germany) 
with two monoclonal antibodies; CD4 Antibody 
(MEM-241) [Phycoerythrin] and CD8 Antibody 
(MEM-31) [Phycoerythrin]. In brief, 20 !l of whole 
blood in EDTA was mixed with 20 !l of CD4 mAb 
PE or CD8 mAb PE and incubated for 15 min at 
room temperature protected from light. Red 
blood cells were then lysed by adding 800 !l of 
fluorescence-activated cell sorter lysing solution. 
After vortex, tubes were incubated in the dark at 
room temperature for 15 min then measured. The 
CA3 software provides instrument control, data 
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acquisition, data analysis, and True Volumetric 
Absolute Counting (Greve, Cassens et al. 2003).
Statistical Analysis
Measurement data among groups were 
expressed as mean ± standard division. Statistical 
analysis was carried out using GraphPad Prism 
version 5 for Windows. Comparison of the means 
was carried out using the student–t test. AP < 0.05 
indicated that the di"erence was significant.
Results 
A total of 110 Libyan women were investigated 
and divided into two groups, 70 pregnant women 
(aged 27.8 ± 2.99, range 18-40 years old) and 40 
non-pregnant women (aged 22.7±3.01, range 18-40 
years old) included as controls. All cases/controls 
came from Tripoli district except 10 pregnant 
women who came from Zwara district. To ensure 
that all cases/controls are free from infections, 
participants were screened for anti-Toxoplasma 
IgG and IgM antibodies and were seronegative. 
Moreover, all cases/controls were seronegative 
for, HIV, HBV and HCV.
Immunophenotyping of Peripheral Blood 
lymphocytes 
The mean absolute CD4+ and CD8+ cells 
count ± SD and their ranges were calculated and 
compared for the two groups. Table 1 summarizes 
the results of the pregnant women group during 
the three trimesters of pregnancy. The CD4+ cell 
counts range from 685±256 cell/!l at the first 
trimester (T1) and 923±203 cell/!l at T3. While the 
CD8+ ranges from 451±171 cell/!l at T1 and 753±190 
cell/!l at T3. The CD4:CD8 ratio ranges from 
1.5±0.64 at T1 and 1.2±0.36 at T3 (Table 1).  Moreover, 
the mean absolute CD4+ and CD8+ counts ± SD 
for the control group (Non-pregnant women) 
were found to be 1001±232 cell/!l and 717±159 
cell/!l respectively (Table 1). Absolute counts of 
CD4+ and CD8+ cells in pregnant women were 
significantly lower as compared to non-pregnant 
group (P<0.05). A wide variation of CD4+ and 
CD8+ counts was reported between both groups 
(Table 1). During the first trimester of pregnancy, 
there were statistically significant decrease in 
the CD4+ and CD8+ cell counts compared to the 
control group (P<0.05). These values increased 
significantly during the T2 compared to T1. At 
the third trimester, CD4+ and CD8+ cell count 
increased to 923±203 and 753±190 which were 
comparable to the values of the control group and 
did not show statistically significant di"erences 
(P > 0.05) (Table 1).  
Table 1. CD4 and CD8 cell counts and ratios for cases 
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There was no statistically significant change 
in the CD4:CD8 ratio during the first and second 
trimesters, however, it decreased significantly from 
1.5 at T1 and 1.4 at T2 to 1.2 at T3 (P<0.05). Moreover, 
significant decrease of CD4:CD8 was seen between T3 
and control group (Table 1).  Further analysis of our 
results showed that the absolute numbers of the CD4+ 
and CD8+ T-lymphocyte cell counts decreased with 
age for both groups except the CD4+ cell counts for 
the pregnant group (Table 2). 
T-lymphocyte subsets values were 
compared between Tripoli and Zwara districts. 
Significant increase in CD8+-cell counts was 
predicted in Zwara (869± 50 cell/!l) compared 
to Tripoli district (722± 61 cell/!l) only at the 3rd 
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trimester of pregnancy (P < 0.05). However, no 
significant di"erences in CD4+-cell counts were 
found between the two districts for pregnant and 
non-pregnant groups. 
Discussion
In this study, we established reference 
ranges of CD4+ and CD8+ T-lymphocytes for the 
Libyan healthy, HIV, HBV, HCV, and Toxoplasmosis 
seronegative pregnant women and discussed 
their use as prognostic markers. The absolute 
CD4+ and CD8+ cell counts in pregnant were 
significantly lower than non-pregnant women. 
This is consistent with the findings of most of 
studies that examined the e"ect of pregnancy on 
T-lymphocytes counts. Clinical data on pregnant 
women shows a deviation of the immune system 
consistent with a weakening of the cell-mediated 
immunity and strengthening of humeral immunity 
(Wegmann, Lin et al. 1993), which is important 
for the success of pregnancy (McIntire and Hunt 
2005, Aagaard-Tillery, Silver et al. 2006, Hunt 2006, 
Munoz-Suano, Hamilton et al. 2011). 
An Indian study among HIV-negative people 
found absolute CD4+ cell counts to be significantly 
lower in pregnant than in non-pregnant women 
(Dayama, Pandit et al. 2003). An earlier study 
among Africans demonstrated reduced absolute 
values of CD4+, CD8+ and total lymphocytes 
during pregnancy (Vassiliadou and Bulmer 1998). 
However, the mean absolute values of CD4+, 
CD8+ counts in our study were higher than those 
reported from Nigerian (Aina, Dadik et al. 2005) 
and Chinese reports (Jiang, Kang et al. 2004) and 
were comparable to the Indian reports (Murugavel, 
Balakrishnan et al. 2009). The relationship 
between gestational age and T-lymphocyte levels 
in pregnant women varies in the literature. A 
study in Kenya found no relationship between 
gestational age and any immunological variable 
in both HIV-positive and negative women 
(Temmerman, Nagelkerke et al. 1995). Ibitokou et 
al. found significant decrease of CD4+ cell counts 
between the second trimester and delivery of 
the sub-Sahara African women (Ibitokou, Brutus 
et al. 2013). Conversely, Tuomala et al., found an 
increase in CD4+ cell counts of 2.76 cells/uL per 
week of pregnancy during serial measurements 
in pregnant women (Tuomala, Kalish et al. 1997). 
In our study, significant decrease of CD4+ and 
CD8+ cell counts were predicted during the first 
trimester followed by significant increase during 
the second trimester, and were comparable to 
the control group in the third trimester. These 
discrepancies could be related to the significant 
geographical and racial di"erences described in 
earlier studies. For example, CD4+-cell counts for 
Asian was found to be lower than that recorded 
for Caucasians (Lee, Yap et al. 1996), and among 
African populations, healthy Ethiopians (Tsegaye, 
Messele et al. 1999) have markedly lower counts 
Table 2. Age distribution of CD4 and CD8 subset values among pregnant and non-pregnant Libyan women.







 770±119 1022±13815157±623216±8632923 – 27
 739±127 1013±16012118±508139±68421 28 –32
 644±179 999±2976174±645206±84812 33 – 37
 508±7 754±86263±449142±730338 - 40
4070Total
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than those recorded in Uganda (Tugume, Piwowar 
et al. 1995) and Tanzania (Levin, Brubaker et al. 
1996). Hence, this establishment of country-
specific immunehaematological reference values 
in Libya is crucial.
    The CD4:CD8 ratio was comparable to the control 
group during T1 and T2. This indicates uniform 
decrease of the tow lymphocytes subsets during 
these periods. However, the significant decrease 
of the ratio during T3 indicating faster increase 
of CD8 compared to that for CD4 cells during this 
period.
   The CD4+ and CD8+ T-lymphocyte cell counts 
decreased with age for both groups except the 
CD4+ cell counts for the pregnant group. This is 
in agreement with a previous study concluded 
that maternal age had no significant e"ects on 
CD4+ cell count levels in pregnancy (Akinbami, 
Gbadegesin et al. 2015),  and disagrees with the 
results from Abimiku et al. which reported that 
low CD4+ cell count was significantly associated 
with older age(Abimiku, Villalba-Diebold et al. 
2009). Moreover, Lugada et al reported that CD4+ 
cell count is highest during the early years of life, 
declines steadily to stable adult values, and it is 
lowest in the elderly (Lugada, Mermin et al. 2004). 
However, our results are limited with smaller 
sample and need to be validated with larger 
cohorts.
   Geographical variation in the CD8+-cell counts 
has been reported through Zwara district 
compared to Tripoli district at the 3rd trimester of 
pregnancy. Though our sample size is very small, 
these results emphasize the need for further 
investigation on T-lymphocyte counts variation 
between di"erent districts in Libya. There are 
many factors a"ecting the levels of circulating 
lymphocytes and may lead to di"erences across 
regions. This includes genetic makeup, altitude, 
dietary patterns, body mass index and smoking 
habits (Schaberg, Theilacker et al. 1997, Feldman, 
Minko" et al. 2006, Mair, Hawes et al. 2008).The 
influence of these factors point out to the fact 
that the T-lymphocytes reference ranges of one 
population might not be precisely used as a 
reference range for another, and might give an 
inaccurate interpretation of the immune status.
The findings of the present study though 
important, are limited with small sample 
size and restricted to two districts and hence 
cannot be generalized. Another limitation is 
that the samples were collected during 2008-
2009 and that current values can vary according 
to environmental and nutritional conditions. 
Nevertheless, our study design was unique since 
we evaluated the T-lymphocytes counts during 
the three trimesters, while most of studies in 
the literature were conducted only on the first 
trimester of pregnancy.
   The lymphocytes reference values have been 
established by many studies throughout the 
world and have shown some variability according 
to geographical locations and methodology 
(Bosire, Nyamache et al. 2013). The validity of 
comparison of CD4+ and CD8+ cell counts depend 
on the comparability techniques, duration and 
temperature of sample storage which could di"er 
significantly between studies.
   Moreover, assay variations may be attributed 
largely to processing methods, monoclonal 
antibodies, analysis methods and lag period 
between drawing blood and processing of the 
specimen (Landay and Muirhead 1989). Hence, the 
use of single – platform flow cytometry, and quality 
control of this platform are recommended to 
eliminate some of the variability between di"erent 
studies and making them more comparable. This 
platform should be used for future studies in order 
to ensure correct comparability and interpretation 
of the results (Chng, Tan et al. 2004).
Conclusions
   In conclusion, the establishment of normal 
ranges for T-lymphocytes with the local 
population is a helpful tool to clinicians for the 
better clinical management of pregnancy specific-
diseases in Tripoli and other surrounding areas, 
and they are used for clinical classification, to 
determine prognosis, and to decide whether to 
prescribe prophylaxis for opportunistic infections 
especially Toxoplasmosis which is highly 
prevalent in Libya. Further cohorts with greater 
Amro, A. et al., Al-Quds J Acad Res  2021: 1(1):53-62
59
sample size may be required to define the stage 
of the disease in relation to the normal CD4+ and 
CD8+ T lymphocyte count subsets in the Libyan 
population.
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